Compounds > dactinomycin

dactinomycin and Endothelioma, Vascular

dactinomycin has been researched along with Endothelioma, Vascular in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gunji, Y; Kanai, N; Kashii, Y; Momoi, MY; Odaka, J; Saito, M; Yamauchi, T1
Fuchimoto, Y; Hirobe, S; Kamagata, S; Kumagai, M; Kuroda, T; Matsuoka, K; Morikawa, N; Morikawa, Y1
Graubner, U; Hauer, J; Konstantopoulos, N; Pfluger, T; Schmid, I; Schmidt, S1

Other Studies

3 other study(ies) available for dactinomycin and Endothelioma, Vascular

ArticleYear
Refractory kaposiform hemangioendothelioma that expressed vascular endothelial growth factor receptor (VEGFR)-2 and VEGFR-3: a case report.
    Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Benzamidines; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Guanidines; Hemangioendothelioma; Humans; Immunohistochemistry; Infant; Interferon-alpha; Magnetic Resonance Imaging; Male; Oleic Acids; Platelet Transfusion; Prednisolone; Prognosis; Sclerosing Solutions; Sclerotherapy; Soft Tissue Neoplasms; Thrombocytopenia; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factor Receptor-3; Vincristine

2009
Vincristine, actinomycin D, cyclophosphamide chemotherapy resolves Kasabach-Merritt syndrome resistant to conventional therapies.
    Pediatrics international : official journal of the Japan Pediatric Society, 2012, Volume: 54, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Hemangioendothelioma; Humans; Infant, Newborn; Kasabach-Merritt Syndrome; Male; Platelet Count; Sarcoma, Kaposi; Treatment Failure; Vincristine

2012
Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach-Merritt phenomenon using four-drug regimen.
    Pediatric blood & cancer, 2007, Volume: 49, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cortisone; Critical Illness; Cyclophosphamide; Dactinomycin; Female; Hemangioendothelioma; Humans; Infant; Interferon-alpha; Methotrexate; Remission Induction; Thoracic Neoplasms; Vincristine

2007